Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BOOG 2017-03: Endocrine Therapy Plus CDK 4/6 Inhibition in First- or Second-line for Hormone Receptor Positive Advanced Breast Cancer - the SONIA Study

NCT03425838 is registered in ClinicalTrials.gov with Borstkanker Onderzoek Groep as lead sponsor.

NCT NCT03425838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03425838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BOOG 2017-03: Endocrine Therapy Plus CDK 4/6 Inhibition in First- or Second-line for Hormone Receptor Positive Advanced Breast Cancer - the SONIA Study
Lead sponsor
Borstkanker Onderzoek Groep
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 9, 2017
Completion date
December 31, 2028
Enrollment
1,050 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female